Kidney Research and Clinical Practice

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of immunoglobulin A nephropathy

Sang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, Young Sun Kang, Dae Ryong Cha

Kidney Res Clin Pract. 2021;40(1):69-76. Published online March 12, 2021
DOI: https://doi.org/10.23876/j.krcp.20.157

Serum interferon-γ and urinary monocyte chemoattractant peptide-1 are important factors in the pathogenesis of IgA nephropathy

Sang Youb Han, Kyung Hwan Jeong, Chun-Gyoo Ihm, Young Sun Kang, Dae Ryong Cha

Kidney Research and Clinical Practice. 2021;40(1):69-76

Link1

Link2 Link3

Urinary levels of epidermal growth factor, interleukin-6 and monocyte chemoattractant protein-1 may act as predictor markers of renal function outcome in immunoglobulin A nephropathy

MARIA STANGOU, EFSTATHIOS ALEXOPOULOS, AIKATERINI PAPAGIANNI, AFRODITI PANTZAKI, CHRISTOS BANTIS, SPIROS DOVAS, DOMNIKI ECONOMIDOU, MARIA LEONTSINI, DIMITRIOS MEMMOS

Nephrology. 2009;14(6):613-620

Link1 Link2

Serum Cytokine Concentrations in Patients with Cervical Cancer: Interleukin-4, Interferon-γ, and Monocyte Chemoattractant Protein-1

Antje Lebrecht, Lukas Hefler, Clemens Tempfer, Heinz Koelbl

Gynecologic Oncology. 2001;83(1):170-171

Link1 Link2

Advances in Genetics of Immunoglobulin A Nephropathy

Hong Zhang, Riccardo Magistroni, Ali Gharavi

Pathogenesis and Treatment in IgA Nephropathy. 2016;19-42

Link1

Predicting outcome of IgA nephropathy by use of urinary epidermal growth factor: monocyte chemotactic peptide 1 ratio

Takashi Wada

Nature Clinical Practice Nephrology. 2008;4(4):184-185

Link1 Link2

Link3

Serum Monocyte Chemoattractant Protein-1 and Monocyte Adhesion Molecules in Type 1 Diabetic Patients with Nephropathy

Sinem Kiyici, Erdinc Erturk, Ferah Budak, Canan Ersoy, Ercan Tuncel, Cevdet Duran, Barbaros Oral, Deniz Sigirci, Sazi Imamoglu

Archives of Medical Research. 2006;37(8):998-1003

Link1 Link2

Monocyte chemoattractant protein-1 A-2518G gene polymorphism and renal survival of Japanese patients with immunoglobulin A nephropathy

Honami Mori, Yoshikatsu Kaneko, Ichiei Narita, Shin Goto, Noriko Saito, Daisuke Kondo, Fuminori Sato, Junya Ajiro, Daisuke Saga, Asa Ogawa, Minoru Sakatsume, Mitsuhiro Ueno, Kaoru Tabei, Fumitake Gejyo

Clinical and Experimental Nephrology. 2005;9(4):297-303

Link1

Link2 Link3 Link4

Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease

Toshiaki Jibiki, Masaru Terai, Masayuki Shima, Atsushi Ogawa, Hiromichi Hamada, Masaki Kanazawa, Shigenori Yamamoto, Shinji Oana, Yoichi Kohno

Arthritis & Rheumatism. 2001;44(9):2211-2212

Link1 Link2

Monocyte chemoattractant protein-1 (MCP-1) is a prognostic biomarker and a therapeutic target in diabetic nephropathy

Frederick W.K. Tam

Meta Gene. 2018;17:S12-S13

Link1 Link2

Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy

O.G. Shaker, N.A.H. Sadik

Human & Experimental Toxicology. 2013;32(10):1089-1096

Link1 Link2 Link3